Big pharma accused of ‘free-riding on nature’ as global fund attracts just $7,000
Why This Matters
Key context: <p>The Cali Fund, set up to raise $1bn a year for biodiversity from drug companies, remains near empty</p><p>Big pharmaceutical companies have been accused of “free-riding on nature”, after a landmark biodiversity fund that invites businesses to put some of their profits back into conservation was left virtually empty.</p><p><a href="https://thecalifund.org/">The Cali Fund</a> set out to raise $1bn (£750m) annually, by asking companies that profit from nature’s genetics to contribute towards conservation in low-income countries. But more than 18 months after the fund was launched, it remains far below this target.</p> <a href="https://www.theguardian.com/environment/2026/oct/22/cop17-cali-conservation-fund-pharmaceutical-freeriding-nature-aoe">Continue reading...</a> This development from The Guardian highlights ongoing changes in the sector.
The Cali Fund, set up to raise $1bn a year for biodiversity from drug companies, remains near emptyBig pharmaceutical companies have been accused of “free-riding on nature”, after a landmark biodiversity fund that invites businesses to put some of their profits back into conservation was left virtually empty.The Cali Fund set out to raise $1bn (£750m) annually, by asking companies that profit from nature’s genetics to contribute towards conservation in low-income countries. But more than 18 months after the fund was launched, it remains far below this target. Continue reading...
Curation & Context
This page summarizes a public news report from The Guardian. Global News Hub provides the "Why This Matters" takeaway using editorial insights and AI curation to give readers rapid, high-value context before they click through to read the full article.